Pri­vate eq­ui­ty groups bag Sta­da in $5.6B buy­out; Jef­feries sees de­te­ri­o­rat­ing prospects for As­traZeneca

→ The gener­ics busi­ness is con­tin­u­ing to con­sol­i­date. Bain and Cinzen have done a deal to ac­quire Ger­many’s Sta­da for $5.6 bil­lion. The pri­vate …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.